1. Decision aid for patients and their family doctors on PSA testing will increase quality of decision (increase knowledge and decrease decisional conflict) 2. Substitution of parts of care after prostatectomy from urologists to general…
ID
Bron
Verkorte titel
Aandoening
Prostate cancer, transmural care, decision aid, SDM, Follow-up care, Substitution, Family doctors or General practitioners, Prostaatkanker, Keuzehulp, Samenwerking tussen eerste lijn en tweede lijn.
Ondersteuning
Primary Sponsor/Performer: Radboud University Nijmegen Medical center
Other performers: CWZ in Nijmegen, Maashospital Pantein in Boxmeer
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Satisfaction of patients. <br>
Use of specialist care (Urology)
Achtergrond van het onderzoek
This project focuses on the collaboration between first and second line care for prostate cancer. Our aim is to set up and evaluate new working arrangements between urologists and general practitioners across the spectrum of the care path, from diagnosis to aftercare.
1. For the diagnostic phase, a decision aid will be introduced to help patients and their general practitioners to decide on whether or not to perform a PSA test. And in case PSA is tested, decision trees are set up for the general practitioners on when to refer or retest.
2. For the aftercare after prostatectomy, substitution of care from urologist to general practitioner is set up for some of the follow-up visits, i.e. at 6, 9, 18 and 30 months or more after surgery.
To evaluate the new methods, questionnaires are sent out to men in the diagnostic phase and men in the aftercare phase. Satisfaction, knowledge and decisional conflict of men receiving care according to the new protocols will be compared to that of men in usual care. In addition, the number of PSA tests ordered and the use of specialist care will be assessed.
Doel van het onderzoek
1. Decision aid for patients and their family doctors on PSA testing will increase quality of decision (increase knowledge and decrease decisional conflict)
2. Substitution of parts of care after prostatectomy from urologists to general practitioners will lower the use of specialist care and will not negatively affect patients' satisfaction
Onderzoeksopzet
1. After consultation with the family doctor
2. 6 and 9 months after prostatectomy
Onderzoeksproduct en/of interventie
1. Men who consider PSA testing will be counseled by their family doctor using a decision aid. These patients will be compared to men who receive usual care from their family doctor with regard to PSA testing (without decision aid).
2. Some follow-up visits after radical prostatectomy (at 6, 9, 18 and 30 months or more) will be scheduled at the family doctor instead of the urologist. These patients will be compared to patients who have all follow-up visits at the Urology department.
Algemeen / deelnemers
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Wetenschappers
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Healthy men who consider PSA testing.
2. Men who had prostatectomy for localized prostate cancer
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Insufficient knowledge of the Dutch language.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6409 |
NTR-old | NTR6585 |
Ander register | Radboudumc : CZ 201600197 |